[HTML][HTML] GammaTile: Comprehensive review of a novel radioactive intraoperative seed-loading device for the treatment of brain tumors

C Ekhator, I Nwankwo, E Rak, A Homayoonfar… - Cureus, 2022 - ncbi.nlm.nih.gov
GammaTile is a Food and Drug Administration (FDA)-licensed device consisting of four
cesium-131 (Cs-131) radiation-emitting seeds in the collagen tile about the postage stamp …

Radioactive iodine-125 in tumor therapy: advances and future directions

S Wei, C Li, M Li, Y Xiong, Y Jiang, H Sun, B Qiu… - Frontiers in …, 2021 - frontiersin.org
Radioactive iodine-125 (I-125) is the most widely used radioactive sealed source for
interstitial permanent brachytherapy (BT). BT has the exceptional ability to deliver extremely …

Review of current principles of the diagnosis and management of brain metastases

AW Brenner, AJ Patel - Frontiers in Oncology, 2022 - frontiersin.org
Brain metastases are the most common intracranial tumors and are increasing in incidence
as overall cancer survival improves. Diagnosis of brain metastases involves both clinical …

Low-Energy X-Ray Intraoperative Radiation Therapy (Lex-IORT) for resected brain metastases: A single-institution experience

CD Diehl, SU Pigorsch, J Gempt, SM Krieg, S Reitz… - Cancers, 2022 - mdpi.com
Simple Summary Advances in systemic cancer management have improved survival for
numerous types of solid cancer; therefore, the number of patients harboring BM is …

Outcome assessment of intraoperative radiotherapy for brain metastases: results of a prospective observational study with comparative matched-pair analysis

JP Layer, M Hamed, AL Potthoff… - Journal of Neuro …, 2023 - Springer
Purpose Intraoperative radiation therapy (IORT) is an emerging alternative to adjuvant
stereotactic external beam radiation therapy (EBRT) following resection of brain metastases …

Benchmarking safety indicators of surgical treatment of brain metastases combined with intraoperative radiotherapy: results of prospective observational study with …

M Hamed, AL Potthoff, JP Layer, D Koch, V Borger… - Cancers, 2022 - mdpi.com
Simple Summary Patients with brain metastasis (BM) are at advanced stages of metastatic
cancer, and surgical resection is often required in order to avoid severe neurologic deficits …

Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors

WC Chen, M Lafreniere, C Phuong, SJ Liu… - Journal of …, 2022 - thejns.org
OBJECTIVE The authors' objective was to examine the safety and efficacy of salvage
intracranial cesium-131 brachytherapy in combination with resection of recurrent brain …

Hypofractionated stereotactic radiation therapy for intact brain metastases in 5 daily fractions: effect of dose on treatment response

S Myrehaug, J Hudson, H Soliman, M Ruschin… - International Journal of …, 2022 - Elsevier
Purpose Multileaf collimator (MLC) linear accelerator (Linac)–based hypofractionated
stereotactic radiation therapy (HSRT) is increasingly used not only for large brain …

Surgery, stereotactic radiosurgery, and systemic therapy in the management of operable brain metastasis

R Kotecha, MS Ahluwalia, V Siomin… - Neurologic …, 2022 - neurologic.theclinics.com
With an increasing proportion of the population being of advanced age, the prevalence of
brain metastases is likely to become a more important part of the practice of future …

[HTML][HTML] The role of brachytherapy in the management of brain metastases: a systematic review

B Chitti, S Goyal, JH Sherman, A Caputy… - Journal of …, 2020 - ncbi.nlm.nih.gov
Purpose Brain metastases have a highly variable prognosis depending on the primary tumor
and associated prognostic factors. Standard of care for patients with these tumors includes …